Home Cart Sign in  
Chemical Structure| 1025015-40-0 Chemical Structure| 1025015-40-0

Structure of GK921
CAS No.: 1025015-40-0

Chemical Structure| 1025015-40-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GK921 is a transglutaminase 2 (TGase2) inhibitor with an IC50 of 7.71 μM for human recombinant TGase2.

Synonyms: GK921

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GK921

CAS No. :1025015-40-0
Formula : C21H20N4O
M.W : 344.41
SMILES Code : C12=NC=CC=C1N=C(OCCN3CCCC3)C(C#CC4=CC=CC=C4)=N2
Synonyms :
GK921
MDL No. :MFCD28167818
InChI Key :MNYJJHBAEYKXEG-UHFFFAOYSA-N
Pubchem ID :56682080

Safety of GK921

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
A549 1 µM 8 hours Evaluate cytotoxicity, showing low cytotoxicity PMC6319544
HCT116 1 µM 8 hours PMC6319544
MCF7 1 µM 8 hours PMC6319544
Mouse fetal liver-derived erythroid cells 0.4 μM and 0.5 μM 4 days Inhibition of TGM2 cross-linking activity significantly reduced the enucleation efficiency of mouse fetal liver-derived erythroid cells. PMC10164954
CAKI-1 1 µM 8 hours GK921 treatment significantly reduced LC3 levels and decreased autophagy activity. PMC6319544

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.90mL

0.58mL

0.29mL

14.52mL

2.90mL

1.45mL

29.04mL

5.81mL

2.90mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories